GFAP and Lewy body dementia: Similarly, GFAP is also elevated in DLB and evidence suggests it is a marker of amyloid pathology, showing preferential increases in post-mortem and CSF Aβ+ individuals with DLB, and it has been associated with lower MMSE scores [101,103▪,113].